| Objective: To explore the clinical efficacy of low frequency pulse electrical stimulation combined with intramuscular injection of mouse nerve growth factor in the treatment of peripheral facial paralysis (PFP) and its effect on facial nerve function, erythrocyte immune adhesion function and superoxide dismutase (SOD). Methods: Totally, 150 cases of PFP admitted to our hospital from May 2020 to September 2021 were selected as the research objects. They were randomly divided into the combined group (75 cases) and the control group (75 cases). The control group was given intramuscular injection of mouse nerve growth factor, and the combined group was given low-frequency pulse electrical stimulation on the basis of the control group. The clinical efficacy of low frequency pulse electrical stimulation combined with intramuscular injection of mouse nerve growth factor, and its effect on facial nerve function, erythrocyte immune function and SOD in two groups were evaluated. Results: After treatment, the total effective rate in the combined group was 97.33% (73/75), significantly higher than 77.33% (58/75) in the control group (P<0.05). Compared with those before treatment, blink reflex (BR) latency and facial nerve compound muscle action potential (CMAP) amplitude were significantly decreased, facial nerve index, erythrocyte immune complex rosette rate (rbc-icr) and SOD were significantly increased in the two groups after treatment (P<0.05). After treatment, the levels of BR latency and CMAP amplitude in the combined group were lower than those in the control group, and the nerve index, facial nerve function score, rbc-icr and SOD in the combined group were higher than those in the control group (P<0.05). Conclusion: Low frequency pulse electrical stimulation combined with mouse nerve growth factor injection can significantly improve the facial nerve function, erythrocyte immune adherence function, enhance the body’s ability to resist free radical injury, and improve the clinical efficacy of PFP. |
